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Summary.-Lymphocytes from 13 chronic myeloid leukaemia (CML) patients in
remission were tested for their ability to differentiate in vitro into a cell population
cytotoxic to autochthonous target leukaemic cells. CML remission lymphocytes were
cultured in vitro with autochthonous leukaemic cells and allogeneic normal lympho-
cytes from an unrelated donor, singly or in combination. The cytotoxic lymphocytes
obtained after 7 days of culture were tested for their ability to kill autochthonous
leukaemic cells in a 3h 5lCr-release assay. It was found that with the allogeneic
stimulus alone, cytotoxicity was generated in 5/13 cases, whilst stimulation of
lymphocytes with autochthonous leukaemic cells alone induced cytotoxicity in 7/13
cases. In contrast, anti-leukaemic cytotoxicity was shown in 12/13 cases when
responder lymphocytes were stimulated with both autochthonous leukaemic and
unrelated allogeneic normal lymphocytes.
The specificity of cytotoxicity was confirmed using other targets such as autoch-
thonous PHA-transformed lymphoblasts and mouse L1210 cells. In 1/5 cases, CML
remission lymphocytes stimulated with autochthonous leukaemic cells showed
cytotoxicity to PHA-transformed autochthonous normal lymphoblasts, whilst 1/4
patients showed nonspecific cytotoxicity to L1210 cells when lymphocytes were
cultured in MLC or MLTC, as well as in a 3-cell assay.
LEUKAEMIA-ASSOCIATED immune reacti-
vity in leukaemic patients has been
shown and confirmed by several workers
using in vitro humoral and cell-mediated
immunological parameters (Powles et al.,
1971; Leventhal et al., 1972; Harris, 1973;
Durantez et al., 1]975; Garrett et al., 1977).
Among the in vitro parameters, lympho-
cyte-mediated cytotoxicity has often been
used for the detection of leukaemia-
associated antigens on leukaemic cells
(Leventhal et al., 1972; Rosenberg et al.,
1972; McCoy et al., 1974). It is, however,
difficult to ascertain that the in vitro
demonstration of target-cell lysis is a
function of sensitized T cells. Human
leukaemic blasts are possibly unable to
induce cytotoxic responses in autologous
remission lymphocytes (Zarling et al.,
1976; Lee & Oliver, 1978). It was felt that
if the stimulator cells did not differ from
the responders with respect to LD anti-
gens, proliferative and cytotoxic responses
would not be easily generated (Zarling et
al., 1976; Zarling & Bach, 1979). Sondel
et al. (1976) incubated lymphocytes of
HLA-identical siblings of patients with
acute leukaemia with allogeneic lympho-
cytes and patients' blasts and demon-
strated specific cytotoxicity to leukaemic
blasts in 3/4 cases. Zarling et al. (1976) also
showed that addition of helper stimulus
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enhances anti-leukaemic cell-mediated
cytotoxicity in acute-leukaemic patients.
Lee & Oliver (1978) extended this work
further to demonstrate in vitro generation
of cytotoxicity with third-party allogeneic
stimulus in 11/14 AML patients. Their
experiments confirmed that the cyto-
toxicity was mediated by T lymphocytes.
Our previous studies on chronic myeloid
leukaemia (CML) have shown that CML
patients in remission demonstrated cellu-
lar sensitization to CML-associated anti-
gens, as tested by in vitro lymphocyte
blastogenesis and leucocyte migration
inhibition assays (Gangal et at., 1976;
Gothoskar et al., 1976; Damle et al., 1979).
CML remission lymphocytes also showed
reactivity to other myeloid or lymphoid
leukaemic blast antigens (Gangal et al.,
1979). The present investigations were
undertaken to find out whether lympho-
cytes from CML patients in remission are
able to differentiate in vitro so as to be
cytotoxic to autochthonous target leu-
kaemic cells.
MATERIALS AND METHODS
A total of 13 untreated CML patients were
used for this study. The peripheral-blood
leucocyte count ofthese CML patients varied
from 15 to 20 x 104 cells/mm3, the M/E ratio
being between 10 and 30 before treatment.
The leukaemic cells were cryopreserved at
this stage in Dulbecco's medium supple-
mented with 10% foetal calf serum (FCS,
Difco) and 10% dimethyl sulphoxide (DMSO)
at a concentration of 1-2x 106 cells/ml in
liquid N2. The cryopreserved cells were
thawed in two lots, one for in vitro sensitiza-
tion, the second being thawed after 7 days
and used for labelling with 51chromium. The
cells were rapidly thawed and slowly sus-
pended and washed in the medium (Dul-
becco's medium+10% FCS+4 lnM/ml L-
glutamine). The viability of thawed cells
was > 80% in all cases.
In vitro sensitization.-The patients
attained clinical and haematological re-
missionafterbusulphantreatment.Whenthey
were in complete remission and off the
therapy for 1-2 weeks, their peripheral-blood
lymphocytes were used for the experiments.
Lymphocytes were separated using Ficoll-
Hypaque density gradient and washed x 3 in
0.85% saline. The responder cells were finally
suspended in culture medium (Dulbecco's
medium+10% FCS+4 mM glutamine+
5 x 10-5M 2-ME and 100 u/mlofpenicillinand
50 ,ug/ml streptomycin) at a concentration of
106 cells/ml. Peripheral-blood lymphocyte
suspensions from normal healthy unrelated
donors were prepared in a similar way.
Autologous thawed leukaemic cells and allo-
geneic normal lymphocytes were treated with
mitomycin-C (VMC, 25 jig for 106 cells) for
45 min, washed and resuspended in culture
medium at 106 cells/ml. Responder cells
(4 x 106) were co-cultured with 4 x 106 stimu-
lating cells in different combinations, as
shown in the Results. When stimulating cells
were a mixture of two cell types, each popu-
lation consisted of 2 x 106 cells. The cell mix-
tures consisting of responder and stimulator
cells were spun at low speed and incubated at
37°C in a humidified 5% CO2 atmosphere for
6-7 days.
51Cr release assay.-Frozen autologous
leukaemic cells were thawed on the 7th day,
washed and resuspended in culture medium.
Cells (2 x 106) were labelled with 200 ,uCi of
5ICr (sodium chromate, sp. act. 15 mCi/mg of
sodium chromate, BARC, Bombay, India)
for 3 h at 37°C in a water-bath with inter-
mittent shaking. The labelled cells were
washed x 3 with tissue-culture medium and
suspended in the medium at 105 cells/ml.
Other target cells were also labelled with 51Cr
in the same way. Responder cells cultured in
different combinations for 7 days were har-
vested, washed and suspended at a concen-
tration of 106 viable cells/ml in the medium.
The viability of responding cell populations
varied between 45 and 67%. Viable cells (106)
were mixed with 104 labelled target cells in
duplicates. The tubes were spun at a very low
speed for 5 min and incubated at 37°C for 3 h.
Two tubes were incubated with labelled
target cells alone to find out the background
(spontaneous) 51Cr release. Two tubes with
104 target cells were frozen and thawed x 5 in
0-5 ml distilled water to determine the maxi-
mum release (100%) ofradioactive chromium.
After 3 h, 0 3 ml ofmedium was added to each
tube, the cells were resuspended and tubes
were centrifuged. Two 0 1ml lots ofsupernate
from each culture was used for counting the
release of 51Cr using a Biogamma Counter
(Beckmann).
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The percentage cytotoxicity was measured
by the standard formula:
% Cytotoxicity=
Experimental release
-Mean spontaneous release x 100
Mean maximal release
-Mean spontaneous release
The spontaneous release of 51Cr did not
exceed 25% in any of the experiments from
which the data are presented and analysed.
Percentage cytotoxicity was calculated for
each of the quadruplicate samples and ex-
pressed as mean % cytotoxicity ± s.e. The
data are analysed using Student's t test.
RESULTS
Results of the cytotoxicity assay of
cultured lymphocytes from 13 CML
patients in remission on autochthonous
target leukaemic cells are in Table I. The
culture combinations consisted oflympho-
cytes (a) incubated without stimulator
cells, (b) stimulated with allogeneic
lymphocytes, (c) incubated with autoch-
thonous leukaemic cells, and (d) incubated
with a combination of autochthonous
leukaemic cells and allogeneic lympho-
cytes. All the stimulator cells were treated
with MMC. The results are expressed as
mean percentage cytotoxicity of quadru-
plicate samples + s.e. It can be seen that
allogeneic stimulus alone induced re-
mission lymphocytes to express cyto-
toxicity to autochthonous target leu-
kaemic cells in 5/13 cases, when compared
with the cytotoxicity of lymphocytes
incubated in culture medium alone, whilst
stimulation of lymphocytes with autoch-
thonous leukaemic cells alone induced
cytotoxic responses in 7/13 cases. It was
interesting to note that in 12/13 cases
highly significant cytotoxic responses were
obtained when leukaemic cells were used
as stimulators along with the third-party
allogeneic lymphocyte stimulus. The cyto-
toxicity in the 3-cell assay was higher than
when by stimulating the lymphocytes
with autochthonous target cells alone.
In Table II are given the results of
experiments on 5 remission lymphocyte
samples where PHA-transformed autoch-
thonous lymphoblasts and xenogeneic
mouse L1210 cells have also been used as
targets, besides autochthonous leukaemic
cells. Lymphocyte cultures treated with
PHA had 58-65% blasts. It can be seen
that in 1/5 tests (AJ 13455) CML re-
mission lymphocytes stimulated with
leukaemic cells have shown cytotoxic
response towards normal autochthonous
PHA-transformed lymphoblasts. In 1/4
tests (AJ 13595) the MLC and MLTC, as
TABLE I.-Generation of cytotoxicity in vitro in CML remission lymphocytes
% Cytotoxicity* by cultured lymphocytes stimulated** with
Allogeneic
lymphocytes
304+ 2-1***
34-8+ 2-5***
48-4 +3-7***
32-5+ 6-0
32-2 + 6-0
25-2+3-0
18-1_ 1-6
30-1+ 1-4
29-9 + 2-2***
22-0+ 1-9
28-4+ 1-6
32-8 + 2-5***
20.1 + 1-4
Auto CML cells
51-8 + 3-1***
40-1+ 2-5***
27-0 + 3-1***
34-2+4-0
42-0+ 5-7
27-2 + 1-7***
28-5 + 1-8***
40-4 + 4.5***
32-3 + 2.3***
27-4 + 2-4
31-6+4-1
36-0 + 3-3***
21-8 + 1-9
Allogeneic
lymphocytes and
auto CML cells
62-2 + 3-5***
73-9 +7.0***
77-2+ 3-1***
67-1 + 4-95***
48-0 + 3-2
65-1 + 4-2***
52-0+ 3-1***
57-5 + 4-2***
52-0+ 3-1***
39 7 + 1-4***
49-5 + 1-4***
34-6 + 16***
36-3+ 1-9***
* Mean + s.e.
** Stimulator cells treated with MMC.
*** P < 0-001 (analysed by Student's t test).
2
Lymphocyte
donors
(CML
remission
patients)
AJ 10227
AK 14634
AK 17728
AK 12468
AH 11282
AJ 930
AK 10429
AL 2909
AH 5593
AH 13595
AJ 13455
AK 11024
AL 1021
Nil
10+3
15+4
8+2
26+4
50+6
11+2
20+2
22+5
15+3
25+4
25+6
7+2
21+5
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TABLE II.-Generation of cytotoxicity in vitro in CML remission lymphocytes
% Cytotoxicity* by cultured lymphocytes stimulatedt witli
Targets
AK 12468§ Auto CML cells
Auto PHA blasts
L1210
AJ 13595 Auto CML cells
Auto PHA blasts
L1210
AH 11282 Auto CML cells
Auto PHA blasts
L1210
AK 17728 Auto CML cells
Auto PHA blasts
L1210
AJ 13455 Auto CML cells
Auto PHA blasts
Auto marrow cells
L1210
Nil
26-1 + 4-0
29-0 + 8-0
22-0 + 3-4
24-8 + 4-0
30 0+ 3 0
6-2+2-1
50-1+6-0
6-0+ 1-2
8-0+2-1
7-9+2-0
41-1 + 4-1
N.D.
25-2+6-0
4-5_+1-1
18-9 + 4-4
8-1 + 2-4
Allogeneic
lymphocytes
32-5 + 6-0
33 0+ 4 7
6-0+ 1-9
22-8+ 1 9
300+3-1
25-0+4-1
(P< 0-01)
32-2 + 6-0
8-0+ 2-0
2-0+ 1.1
48-4 +3-7t
45*0+ 8-0
N.D.
28-4+ 1-6
16-4+5-1
21-4+ 6-0
6-4+ 1-8
Auto
CML cells
34-2+4-0
31-0+ 3-8
6-0+ 2-9
27-4 + 2-4
36 7 + 6-0
26-7 + 3-8
(P < 0-002)
42-0+ 5-7
7-0+ 3 7
4-0+2-1
27-0+ 3-1l
43-0+ 110
N.D.
31-6+4-1
22-1+ 3-1
(P < 0.002)
19-7+ 3-0
8-7 + 2-8
Allogeneic
lymphocytes
+ Auto
CML cells
67-1 +4-9t
33-9+5-1
14-0+5-1
39-7 +1-4T
32-9+ 59
19-6+ 3-1
(P < 0*02)
48-0 + 3-2
12-0+ 3-1
7-5+1*9
77-2+3-IT
48-1 + 13-1
N.D.
49 5 + 1-4t
15-5+ 4-3
39 3 + 3 0:
11-8+ 3-7
* Mean + s.e. t Stimulator cells tieated with MMC.
: P < 0-001 (analysed by Student's t test). § Remission lymphocytes from.
well as 3-cell culture, seemed to induce
nonspecific cytotoxicity to mouse L1210
cells. However, the specific leukaemic
target cell lysis in these experiments was
higher than other targets.
Lymphocytes stimulated in vitro were
tested on target autochthonous marrow
cells in one case (AJ 13455). It is interest-
ing to note that lymphocytes of this
patient, when stimulated with autologous
leukaemic cells and allogeneic lympho-
cytes, showed significant cytotoxicity to
autologous marrow cells.
DISCUSSION
In the present series of experiments it
has been shown that CML remission
lymphocytes can differentiate in vitro into
a cell population highly cytotoxic to
autochthonous leukaemic cells. In our
experiments, in 5/13 cases cytotoxicity to
autologous target leukaemic cells was dis-
played by responders stimulated in one-
way MLC. Addition of LD stimulus by
way ofMLC may have caused proliferation
and differentiation of cells capable of
recognizing target-cell antigens.
Recently, Zarling & Bach (1978) have
shown that normal T lymphocytes, sensi-
tized in vitro against a pool of allogeneic
lymphocytes, lyse autologous EBV-trans-
formed lymphoblastoid cell lines, but not
autologous lymphocytes or mitogen-
inducedblasts. Similarly, theyhavealsode-
monstrated that peripheral-blood lympho-
cytes of 2 hairy-cell leukaemic patients,
stimulated in vitro by a pool of allogeneic
lymphocytes from 20 normal donors, kill
autologous leukaemia target cells (Zarling
et al., 1978). In both these reports, how-
ever, it was stressed that lymphocytes
from a single allogeneic individual are
marginally capable of stimulating T cells
to develop into cytotoxic lymphocytes
(CTL) cytotoxic to autologous leukaemic
or transformed cells, whereas, in our
experiments, the proliferation stimulus
provided by a single allogeneic cell type
appears to be sufficient to generate CTL
reactive to autologous leukaemic cells.
In one of their earlier reports, Zarling
et al. (1976) have demonstrated generation
of CTL cytotoxic to autologous leukaemic
cells after incubating the lymphocytes
f-
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with autologous marrow cells and allo-
geneic lymphocytes. The authors have
suggested that the response could be due
to the presence of a few leukaemic blasts
( 5%) in the marrow. However, it is
possible that the response could be due to
the stimulus provided by allogeneic cells
as shown by us.
Throughout the experiments reported
here, lymphocytes have been cultured in
medium containing FCS. The possibility
that FCS, being mitogenic, may have
reactivated the cytotoxic activity in
patients' in vitro immunized cells cannot
be ruled out.
In the group of CML patients investi-
gated by us, a fair number oflymphocytes
capable of recognizing target-cell antigens
already existed in circulation, since in
MLTC-stimulated cultures 8/13 patients
responded by displaying specific target-
cell lysis. Zarling et al. (1976) have shown
that when leukaemic blasts are used as
stimulators, cytotoxicity was not always
demonstrable. Lee & Oliver (1978) have
shown that myeloid blasts are poor stimu-
lators even in allogeneic stimulation. The
CML leukaemic cell population consists of
cells in different stages of maturation, and
may express antigens which can be recog-
nized by sensitized lymphocytes. Addition
of third-party stimulus has evidently
increased the cytotoxicity of CML re-
mission lymphocytes to target leukaemic
cells.
In the present investigations, besides
autochthonous leukaemic target-cell lysis
(shown by 12/13 patients) 1/5 patients
showed cytotoxicity to PHA-transformed
normal lymphoblasts, and 1/4 patients
showed killing ofLI210 cells. We have not
included stimulator allogeneic normal cells
as targets in this study. Zarling et al. (1976,
1978) and Lee & Oliver (1978) have shown
the lysis of allogeneic stimulator targets
by the responders sensitized in vitro in a
3-cell assay.
It was interesting to note that lympho-
cytes of one patient, sensitized in vitro in
a 3-cell assay, couldkill target autochthon-
ous marrow cells. Although this has been
demonstrated only in one patient, the
findings indicate that the marrow may
have retained abnormal cells during re-
mission. Cytogenetic studies on remission
marrow cells of CML patients have shown
that patients apparently in clinical and
haematological remission may still have
20-30% cells with Philadelphia (Phl)
chromosome and other anomalies (Khare
et al., unpublished data) indicating the
presence of abnormal (leukaemic ?) cells in
their marrow.
A number of attempts have recently
been made to increase the in vitro cyto-
toxicity of sensitized lymphocytes to
specific target cells. These include the use
of helper factor produced by primary or
secondary MLC (Zarling & Bach, 1979;
Wagner, 1978), helper factor produced by
mitogen-activated lymphocytes for main-
tenance of cytotoxic cells in vitro (Gills &
Smith, 1977) or addition of interferon in
the stimulating system (Zarling & Bach,
1979). Using animal models, it has also
been possible to prevent tumour growth
by mixing tumour cells with CTL gener-
ated in vitro (Glaser, 1979). Recent evi-
dence suggest that it is possible to main-
tain specific cytotoxic T cells in vitro by
repetitive MLC stimulus and mitogen-
induced growth factor for 4 months (Gills
& Smith, 1977; Zarling & Bach, 1979). The
system thus has great potential and
applicability in human situations. The
present work suggests that in CML it is
possible to generate a highly cytotoxic
lymphocyte population by using an in
vitro 3-cell system. Attempts will now be
made to maintain the proliferation ofCTL
specifically reactive to target cells using
exogenous growth factors supplied by
conditioned medium.
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